Literature DB >> 23618794

Minimum clinically important differences identified for commonly used depression rating scales.

Sarah C Masson, Aaron M Tejani.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23618794     DOI: 10.1016/j.jclinepi.2013.01.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  20 in total

1.  The effects of aerobic training on subclinical negative affect: A randomized controlled trial.

Authors:  Kathleen M McIntyre; Eli Puterman; Jennifer M Scodes; Tse-Hwei Choo; C Jean Choi; Martina Pavlicova; Richard P Sloan
Journal:  Health Psychol       Date:  2020-01-09       Impact factor: 4.267

2.  Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.

Authors:  Siegfried Kasper
Journal:  Wien Med Wochenschr       Date:  2015-06-20

3.  The effectiveness of e-healthcare interventions for mental health of nurses: A PRISMA-compliant systematic review of randomized controlled trials.

Authors:  Jung-Hyun Park; Su-Eun Jung; Da-Jung Ha; Boram Lee; Myo-Sung Kim; Kyo-Lin Sim; Yung Hyun Choi; Chan-Young Kwon
Journal:  Medicine (Baltimore)       Date:  2022-06-24       Impact factor: 1.817

4.  Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray.

Authors:  Heather Rozjabek; Nan Li; Holger Hartmann; Dong Jing Fu; Carla Canuso; Carol Jamieson
Journal:  J Patient Rep Outcomes       Date:  2022-07-10

5.  Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data.

Authors:  William V Bobo; Gabriela C Angleró; Gregory Jenkins; Daniel K Hall-Flavin; Richard Weinshilboum; Joanna M Biernacka
Journal:  Hum Psychopharmacol       Date:  2016-03-21       Impact factor: 1.672

6.  Emerging New Psychiatric Symptoms and the Worsening of Pre-existing Mental Disorders during the COVID-19 Pandemic: A Canadian Multisite Study: Nouveaux symptômes psychiatriques émergents et détérioration des troubles mentaux préexistants durant la pandémie de la COVID-19: une étude canadienne multisite.

Authors:  Rebecca Robillard; Alexander R Daros; Jennifer L Phillips; Meggan Porteous; Mysa Saad; Marie-Helene Pennestri; Tetyana Kendzerska; Jodi D Edwards; Elizaveta Solomonova; Rajiv Bhatla; Roger Godbout; Zachary Kaminsky; Addo Boafo; Lena C Quilty
Journal:  Can J Psychiatry       Date:  2021-01-19       Impact factor: 4.356

7.  Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.

Authors:  Justyna Pollok; Joep Em van Agteren; Kristin V Carson-Chahhoud
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

8.  Depression, anxiety and quality of life of hemodialysis patients before and during the COVID-19 pandemic.

Authors:  Els Nadort; Nadine Rijkers; Robbert W Schouten; Ellen K Hoogeveen; Willem J W Bos; Louis Jean Vleming; Michiel Westerman; Marcel Schouten; Marijke J E Dekker; Yves F C Smets; Prataap Chandie Shaw; Karima Farhat; Friedo W Dekker; Patricia van Oppen; Carl E H Siegert; Birit F P Broekman
Journal:  J Psychosom Res       Date:  2022-04-14       Impact factor: 4.620

9.  Electroacupuncture plus moxibustion for major depressive disorder: A randomized, sham-controlled, pilot clinical trial.

Authors:  Mikyung Kim; Eun-Ji Choi; O-Jin Kwon; Hyo-Ju Park; Ae-Ran Kim; Bok-Nam Seo; Sun-Yong Chung; Jun-Hwan Lee; Joo-Hee Kim
Journal:  Integr Med Res       Date:  2021-04-23

10.  What's in a Face? Amygdalar Sensitivity to an Emotional Threatening Faces Task and Transdiagnostic Internalizing Disorder Symptoms in Participants Receiving Attention Bias Modification Training.

Authors:  Manivel Rengasamy; Mary Woody; Tessa Kovats; Greg Siegle; Rebecca B Price
Journal:  Cognit Ther Res       Date:  2021-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.